1 Bi-directional GABA-transport was studied by performing uptake and superfusion experiments in human embryonic kidney 293 cells stably expressing the rat GABA transporter rGAT-1. 
Introduction
Neurotransmitters are stored in presynaptic vesicles and released by exocytosis upon Ca 2+ -in¯ux into the presynaptic specialization. The signal is terminated by rapid reuptake of the neurotransmitter by a speci®c Na + -dependent transporter into the synaptic terminal or the surrounding glial cells (Nelson, 1998) . This general model is applicable to essentially all neurotransmitters, notable exceptions being acetyl choline and nucleotides which are hydrolyzed rather than taken up. Among the neurotransmitters using a transporter for signal termination is GABA (g-aminobutyric acid), one of the major inhibitory neurotransmitters in the adult mammalian central nervous system; more than 30% of all synapses use GABA as transmitter (Bloom & Iversen, 1971) . The inhibition of GABA-transport has become increasingly relevant to clinical pharmacotherapy in the past years. Drugs acting on the GABA-transport (like tiagabine or 2,4-diamino-n-butyric acid; DABA) have proven to act anticonvulsively in animal models (Nielsen et al., 1991; Amabeoku & Chikuni, 1993; Taberner & Roberts, 1978; Dalby, 2000) . Changes in the number of GABA transporters have been associated with temporallobe epilepsy (During et al., 1995) and the GABA uptake inhibitor tiagabine is already in use as an antiepileptic drug (Gustavson & Mengel, 1995; Snel et al., 1997; Uthman et al., 1998) . The application of molecular biology to the study of neurotransmitter transporters within the past few years has greatly expanded our knowledge of these molecules and has revealed a far greater complexity of GABA transporters than previously imagined. To date genes for four distinct high-anity GABA transporters have been cloned: GAT-1, GAT-2, GAT-3 and BGT-1 (Guastella et al., 1990; Borden et al., 1992; Liu et al., 1993 reviewed in Borden, 1996 . It is generally assumed that the major physiological function of neurotransmitter transporters is cellular re-uptake of released neurotransmitter; however these transporters are also capable of running backwards and releasing neurotransmitter in a Ca 2+ -independent non-vesicular manner. Carrier-mediated GABA release can be found both on neurons and on glia, induced under the in¯uence of certain drugs, with depolarization or under a decrease in the sodium gradient (Richerson & Gaspary, 1997) . It has been proposed that carrier-mediated GABA release can occur in vivo during high-frequency neuronal ®ring and seizures, activating GABA receptors on hippocampal neurones (Gaspary et al., 1998) , but it can also be observed in the intermediate spiny neurones of the striatum following stimulation by D 1 -dopamine receptors (due to a cyclic AMP/PKA-dependent action on the Na + / K + -pump, see Schoelmeer et al., 2000) . It is common methodology to study neurotransmitter transport in cellular systems containing only the transporter of interest, i.e. uptake and release experiments are performed in cells transfected with the appropriate cDNA: the investigation of reverse transport in these systems, however, has met diculties resulting from methodological limitations. In a typical experiment of this kind cells are grown in wells loaded with radiolabelled neurotransmitters and the eux of the radiolabel from the cells is studied by pipetting medium from the well or by measuring the amount of radiolabel in the cells. Although some meaningful results can be generated in this way, the approach is less than ideal. It does not prevent movement of neurotransmitter molecules across the membrane in both directions (uptake and reverse transport at the same time) and it does not allow a satisfactory time resolution of the process under study. A method was developed in our laboratory allowing the superfusion of transfected cells after they have been loaded with radiolabelled neurotransmitter (Pi¯et al., 1995) . This technique has been used successfully to characterize the rat and the human serotonin transporter Sitte et al., 2000) and has now been applied to study the GABA transporter GAT-1. In most cases superfusion minimizes re-uptake since any released neurotransmitter is washed away immediately by the superfusion buer.
Here we present data on the uptake and eux of [ 3 H]-GABA in human embryonic kidney 293 (HEK-293) cells stably expressing the rat GAT-1. Kinetic constants for inward and outward transport are presented and a complex interaction of the rGAT-1 with the substrate 2,4-diamino-nbutyric acid (DABA) is described.
Methods

Cell culture
The cDNA for the rat GABA transporter (GAT-1) was a generous gift of Dr P. Schloss (Zl fuÈ r seelische Gesundheit, Mannheim, Germany; Sato et al., 1995) . The coding region was subcloned into pRC/CMV (Invitrogen, Carlsbad, CA, U.S.A.).
For stable expression into HEK-293 cells the same method was used as described in Pi¯et al. (1996) . The stable transfectants (rGAT-1 cells) were grown in Dulbecco's minimal essential medium containing L-analyl-L-glutamine (L-glutamax I TM , Gibco Life Technologies, Grand Island NY, U.S.A.), 10% heat-inactivated foetal bovine serum, 50 mg l 71 gentamicin and 500 mg ml 71 geneticin (G418) on 100 mmdiameter cell culture dishes at 378C in an atmosphere of 5% CO 2 , 95% air.
Uptake
The experiments were performed as described previously . In brief, 5610 4 cells were seeded onto poly-D-lysine-coated 48-well plates, and in¯ux was measured 2 days after plating. Each well was washed once with 1 ml of KRH buer (Krebs-Ringer HEPES buer; (mM): HEPES 10, NaCl 120, KCl 3, CaCl 2 2, MgCl 2 2, glucose 20, ®nal pH 7.3). Cells were incubated with 10 nM [ 3 H]-GABA (33 Ci mmol
71
) and various concentrations of unlabelled GABA for 3 min at room temperature. To study drug eects, cells were pre-incubated with the substance of interest for 3 min before adding 10 nM [ 3 H]-GABA and 5 mM unlabelled GABA for another 3 min. Then, the uptake buer was aspirated, the cells were washed twice with ice-cold buer and lysed with 0.5 ml of 1% sodium dodecyl sulphate (SDS). Radioactivity in the lysates was measured by liquid scintillation counting. Non-speci®c uptake was de®ned as uptake in the presence of 10 mM tiagabine (3 min preincubation).
Superfusion
The experiments were performed as described previously . In brief, cells were grown overnight onto poly-D-lysine coated round glass cover slips (diameter 5 mm) at 4610 4 cells/well. Cells were loaded with 50 mM ) for 20 min at 378C in a ®nal volume of 100 ml KRH buer. The cover slips were then transferred to superfusion chambers (200 ml) and superfused with KRH buer (0.7 ml min 71 ) at 258C. After a washout period of 45 min a stable eux was obtained and the experiment was started with the collection of 2 min fractions. After three fractions (t=0) the cells were exposed to the drug of interest and another ®ve fractions were collected. At the end of the experiment cells were lysed in 1% SDS. Tritium in the superfusate fractions and in the SDS lysates was determined by liquid scintillation counting. The release of [ 3 H] was expressed as fractional rate, i.e. the radioactivity released during a fraction was expressed as a percentage of the total radioactivity present in the cells at the beginning of that fraction. Basal eux was de®ned as eux in the absence of the drug, e.g. mean eux collected in fractions 1 ± 3. Drug-induced eux was calculated as the mean value of fractions 6 ± 8 divided by 2 (fraction length=2 min).
Determination of cell numbers per coverslip and estimation of intracellular GABA concentrations
For the estimation of the number of cells used in the superfusion experiments, 4610 4 cells were seeded onto round glass coverslips and grown overnight. Coverslips were transferred to superfusion chambers (200 ml) and superfused with KRH buer (0.7 ml min 71 ) at 258C for 45 min. At the end of the superfusion coverslips were removed, washed with KRH lacking glucose, immersed in 60 ml of 1% SDS and the protein content of the cell lysate was measured (bicinchoninic acid kit, Pierce, Rockford, IL, U.S.A.). Cell numbers were calculated using a standard curve generated on the same day from known amounts of the same cells. This assay was performed in 12 parallel incubations on two dierent days and yielded a mean cell number of 26,406+2659 per coverslip (n=24). Intracellular drug concentrations were calculated from the accumulated radioactivity in the cells, a cell volume of 1.3 pl (see Sitte et al., 2001 ) and a cell number of 27,000 cells per coverslip. 
Data
Chemicals
Tissue culture reagents were from Gibco Life Technologies. Effects of rGAT-1 substrates and rGAT-1 inhibitors on the efflux and uptake of [ H]-GABA eux. Representative eects of GABA and SKF 89976A are shown in Figure  1 . Both drugs caused a concentration ± dependent increase in eux that reached a plateau after 6 min of drug exposure with SKF 89976A being only about one-®fth as eective as GABA. Figure 2a shows concentration ± response curves for various substrates and re-uptake inhibitors of GAT-1, the resulting EC 50 values are given in Table 1 . The maximum eects on eux were 0.3% min 71 for all substrates except GABA (0.44% min 71 ) and 0.12% min 71 for the re-uptake inhibitors. All drugs were also tested for inhibition of [ 3 H]-GABA uptake: the concentration ± response curves are shown in Figure 2b , the corresponding IC 50 values are given in Table 1 . There was a good overall correlation (r 2 =0.99) between the IC 50 values obtained from uptake experiments Table 1 ).
Effects of DABA on uptake and efflux of [ 3 H]-GABA
With regard to the substrates L-DABA and DL-DABA qualitatively dierent results were obtained compared to the substrates guvacine or nipecotic acid. The concentration ± response relationship for the eect on eux (Figure 3a ) was bell-shaped: eux enhancement was maximal at 1 mM, diminished at 3 mM and practically absent at 10 mM. Inhibition of [ 3 H]-GABA uptake ( Figure 3b ) was less pronounced at 3 mM than at 1 mM, but a concentration of 10 mM DABA inhibited uptake completely. In order to Table 1 . The ®ts for L-DABA and DL-DABA were done excluding all data points 41 mM (see also Figure 3a ). (b) Concentration ± inhibition curves of substrates and re-uptake-inhibitors of GAT-1 for their eects on [ 3 H]-GABA uptake. Cells were incubated in 48-well plates (5610 5 cells/well) with 5 mM [ 3 H]-GABA for 3 min at room temperature as described in Methods. Test drugs were added 3 min before [ 3 H]-GABA using at least six dierent concentrations. Nonspeci®c uptake was measured in the presence of 10 mM tiagabine. Symbols represent means+s.e.mean of nine observations (three experiments each performed in triplicate). The data were ®tted by non-linear regression. IC 50 values are given in Table 1 . The ®ts for L-DABA and DL-DABA was done excluding all data points 41 mM (see also Figure 3b ). For experimental details see legend to ®gure 2. *The ®ts for L-DABA and DL-DABA were done excluding all data points 41 mM (see also Figure 3 ). To examine the lack of eect of high concentrations of DABA (1 ± 10 mM) on [ 3 H]-GABA eux more closely, rGAT-1 cells were superfused and dierent concentrations of L-DABA were added to the superfusion buer for a period of 10 min followed by drug-free superfusion for the remainder of the experiment (Figure 5a) . At a concentration of 1 mM L-DABA increased [ 3 H]-GABA-eux which returned to baseline after removal of the drug. By contrast, eux of [ 3 H]-GABA was stimulated only weakly or not at all after addition of higher concentrations of DABA and increased remarkably after the removal of the drug to a level well above the level attained in the presence of 1 mM DABA, and comparable to the eux induced with a saturating concentration of nipecotic acid. An additional set of experiments was performed to study the eects of rGAT substrates and RI on GABA induced [ 3 H]-GABA eux (Figure 5b ). rGAT cells were superfused, and a saturating amount of GABA (333 mM) was included for 10 min followed by additional exposure to the test substances at saturating concentrations. The substrate ]-GABA, superfused, and 2 min fractions collected. GABA (333 mM) was added at 0 min and its concentration kept constant throughout the experiment. At 10 minutes dierent drugs were added to the GABA containing superfusion buer (nipecotic acid: 33 mM, tiagabine: 10 mM, L-DABA: 10 mM) as indicated by the bar. Data are presented as fractional eux, i.e. each fraction is expressed as the percentage of radioactivity present in the cells at the beginning of that fraction. Symbols represent means+s.e.mean of nine observations (one observation=one superfusion chamber; triplicates from three separate experiments).
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Bi-directional transport of GABA H.H. Sitte et alnipecotic acid (33 mM) decreased GABA-induced [ 3 H]-GABA eux slightly whereas the RI tiagabine (10 mM), displayed a more marked eect. However, L-DABA at a concentration of 10 mM completely suppressed the GABA eect with eux reaching basal levels.
Interaction between substrates and blockers of GAT-1
The eect of the potent uptake inhibitor tiagabine on GABAinduced [ 3 H]-GABA release was analysed. After a 10-min exposure to dierent concentrations of tiagabine (0 to 33 mM) GABA (333 mM) was added to the superfusion buer for additional 10 min. As shown in Figure 6 , tiagabine alone increased [ 3 H]-GABA eux in a concentration ± dependent manner, but likewise inhibited further eux induced by GABA. At tiagabine concentrations of more than 33 mM the release-enhancing action of 333 mM GABA was abolished.
Effect of Na + , K + -ATPase inhibition in superfusion experiments
A series of experiments was performed in which the cells were exposed to ouabain, a measure which is expected to raise the intracellular sodium concentration and to facilitate outward transport of substrate. When ouabain (100 mM) was included in the superfusion buer during the 45-min washout period, the eux rate at the beginning of superfusate collection was nearly twice as high as compared to ouabain-free conditions (0.083+0.006% min 71 versus 0.052+0.003%min
71
, n=20). 
Comparison of inward and outward transport rates
A series of experiments was performed, in which initial uptake rates (=Inward Transport Rates) and Outward Transport Rates were determined in parallel. One representative set of experiments is shown in Figure 8 . The uptake experiment in Figure 8a the data points between 4 and 10 min after drug addition and plotting against the estimated intracellular substrate concentration (Figure 8b ). Since the eect caused by tiagabine is supposed to be due to interruption of high anity re-uptake of GABA leaving the cell by diusion, the GABA eect was corrected for the tiagabine-induced eux to obtain transporter mediated release (open squares in Figure 8b ). The intracellular concentration of [ 3 H]-GABA at which the halfmaximal rate of reverse transport was reached (K M for reverse transport) was 12 mM, the maximal velocity for reverse transport was about 50 pmol min 71 10 76 cells.
Discussion
The aim of the present study was to characterize bidirectional GABA transport in cells stably expressing the rGAT-1. For this purpose the eects of re-uptake inhibitors as well as substrates of GAT-1 were studied in uptake and superfusion experiments. While inward transport is easily monitored in uptake assays, outward transport is more dicult to measure as an isolated process. Cells have to be pre-incubated with radiolabelled substrate before outward transport can be induced, and released substrate may be recaptured by ongoing inward transport. For this reason superfusion experiments were performed which rest on the premise that the¯ow rate of the buer is too rapid to permit re-uptake of released transmitter (Raiteri et al., 1974) and thus allow to measure isolated outward transport. When [ 3 H]-GABA labelled cells were exposed to substrates of the rGAT-1 (GABA, nipecotic acid, guvacine, DABA) under superfusion conditions all substances clearly caused outward transport as evidenced by an increase in tritium eux into the superfusion medium. The most active compound proved to be the natural substrate GABA which caused an increase by about a factor of 7 as compared to baseline eux. The other transporter substrates were clearly less eective. A similar result, at least with respect to nipecotic acid, has been observed in CHO cells expressing the rGAT-1 (Corey et al., 1994) . It is assumed that substrates such as nipecotic acid may bind tightly to the GABA binding site but after transport to the intracellular compartment may dissociate slowly from the transporter. This would prevent the binding of intracellular GABA and consequently reduce its outward transport. When well-known inhibitors of GABA uptake were tested in the superfusion experiments, they also caused a small increase in eux from about 0.06% min 71 basal to 0.12% min 71 in the presence of drugs. This is in line with similar ®ndings in other studies, including our own. For instance, a distinct eux enhancing eect of re-uptake inhibitors was seen in experiments using rotating disc electrode voltammetry in cells expressing the human norepinephrine transporter or in superfusion experiments on serotonin transporter expressing cells pre-incubated with [ 3 H]-serotonin Sitte et al., 2000) . The most likely explanation for the observation was drug-induced interruption of ongoing re-uptake of substrate that is leaving the cell by diusion. This seems also true for the present experiments considering that (1) the intracellular concentration of [ 3 H]-GABA is in the millimolar range (Figure 8b ), (2) the anity for GABA inward transport is high, and (3) the expression level of the rGAT-1 is high .
Moreover, exposure of the cells to ouabain, a measure known to cause a rise in the sodium concentration at the inside of the plasma membrane and a decrease in K M value for outward transport (Raiteri et al., 1978; BoÈ nisch, 1986; Liang & Rutledge, 1982) , resulted in a massive enhancement of [ 3 H]-GABA eux induced by all transporter substrates, but not of the eux induced by RI's. This ®nding strongly argues against the possibility that eux induced by re-uptake inhibitors is a consequence of reversed transport and con®rms the previous interpretation of drug induced interruption of re-uptake. The range of IC 50 values obtained in the uptake experiments was 0.1 ± 700 mM, with individual values in very good agreement with the data of Borden et al. (1994) in rGAT-1 transfected LM(tk 7 ) cells. Clark et al. (1992) reported a similar rank order of potencies in HeLa cells transiently expressing rGAT-1, though the absolute potencies were about 10 to 30 times lower than those presented here (Table 1) . One reason for the dierence may be the use of transient transfections by Clark et al. (1992) as opposed to permanent transfection in the present study (for review see Borden, 1996) . Other possibilities are the use of dierent temperatures (378C vs 258C) in the two studies.
A comparison of IC 50 values obtained in uptake experiments with the EC 50 values obtained in superfusion experiments showed a good correlation, the ratios of IC 50 / EC 50 being about unity for almost all substances (Table 1 ). This result is expected for uptake-inhibitors, as they exert the same eect (block of re-uptake) in both types of experiments. It is not as obvious for the substrates which induced outward transport in the same concentration range as they inhibited inward transport. In fact, a similar analysis in the rat serotonin transporter consistently yielded IC 50 /EC 50 ratios of 42 (up to 10; Sitte et al., 2000) , i.e. all transporter substrates acted as preferential releasers. This obviously does not hold true for rGAT-1 substrates.
A noticeable ®nding of the present study concerns the eects of 2,4-diamino-n-butyric acid (DABA), a close structural analogue of GABA. The concentration ± response curve of DABA for inducing eux of radioactivity from [ 3 H]-GABA labelled cells was clearly bell-shaped with a maximum at 1 mM. Interestingly, at the same concentration of DABA a deviation from its concentration ± response curve was seen when the compound was used to inhibit GABA uptake (Figure 3) . A more detailed analysis revealed two types of interaction: L-DABA inhibited [ H]-GABA uptake mediated by rGAT-1 at the very same concentration release is caused. The observed results lead to the conclusion that DABA is transported by GAT-1 through a dierent mechanism than GABA, otherwise the interaction would also be of the competitive type. In fact, it is known from work in synaptosomes that GABA and DABA transport dier in several instances such as the requirements for chloride and potassium (Roskoski, 1981) , the dependence on external sodium (Simon & Martin, 1973; Weitsch-Dick et al., 1978) , or the co-transport of sodium (Erecinska et al., 1986) . Therefore, a complex interaction at the rGAT-1 seems possible.
However, this behaviour of DABA has so far not been described in other experimental systems. Corey et al. (1994) studied inhibition by DABA of GABA uptake in rGAT-1 expressing CHO cells, but did not observe a deviation in the probit analysis. The reason for this result is most likely the use of lower DABA concentrations (50.5 mM) than those used in the present study. However, it is a well known fact, that DABA is able to inhibit GABA uptake (Iversen, 1971) and to stimulate release of the neurotransmitter (Simon et al., 1974) .
Interestingly, a bell-shaped concentration ± response curve for outward transport induced by a transporter substrate is not unique for the rGAT-1. Wall et al. (1995) reported bellshaped curves for various amphetamines in LLC-PK1 cells expressing the dopamine, norepinephrine or serotonin transporter. In addition, Pi¯et al. (1999) described a very similar behaviour of amphetamine at the norepinephrinetransporter expressed in HEK cells: the drug increased eux up to a concentration of 1 mM but suppressed it completely at 100 mM. The authors proposed that amphetamine might interact in two dierent ways with the norepinephrinetransporter: on the one hand as substrate transported into the cell, which is required for its releasing action, on the other hand extracellularly, by blocking with low anity the translocation of substrate in both directions. A similar situation may apply to the present experiments and would account for the observation that no increase in eux of [ 3 H]-GABA was observed when high concentrations of DABA entered the superfusion chamber, but eux promptly occurred after a switch to drug-free buer (Figure 5a ): in the former situation, DABA may block the transporter by interaction with the transport-blocking extracellular site, in the latter, DABA would ®rst be removed from that site and then could trigger outward transport. In line with this idea are the eect sizes in the two types of experiments. The dotted lines in Figure 2 are ®ts of the eects of racemic DABA and L-DABA using only the data points up to the concentration of 1 mM. The ®t indicates a maximum of the same magnitude as with nipecotic acid or guvacine. However, because of the uptake-inhibiting eect, the estimated maximum is not reached and a bell-shaped concentration ± response curve results. On the other hand, when the experiments were performed by ®rst introducing a high concentration of DABA which is subsequently washed away (Figure 5a ), the eect on outward transport reached exactly the same maximum as that of nipecotic acid (guvacine not tested in this experiment). It is conceivable that during exposure of the cells to the high concentration enough DABA entered the cells by diusion to induce outward transport once the extracellular block is released. The ®ndings of Erecinska et al. (1986) may also be of note in this context. The authors studied DABA transport in rat brain synaptosomes and suggested a very close proximity of the amino acid (DABA) binding site and one of the sodium binding sites. The unique nature of DABA's action at the rGAT-1 is also apparent from the results in Figure 5b . When outward transport of [ levels, even lower than tiagabine. Taken together, the present observations support the notion that the interaction of DABA with the rGAT-1 is dierent to the interaction of other drugs targeting this transporter.
In a ®nal series of experiments transport rates of uptake and reverse transport were compared. Our cells apparently accumulate substrate up to millimolar concentrations which is in the same range of values as described in other studies with non-neuronal cell lines expressing neurotransmitter transporters Sitte et al., 2001) . The relationship between the estimated intracellular concentrations of [ 3 H]-GABA and rates of GABA-evoked [ 3 H]-GABA eux displayed saturation kinetics with an apparent K M value of approximately 1000 fold the value found for inward transport (10.8 mM vs 12 mM, Figure 8 ). This is again comparable to results in other cells, e.g. 0.88 mM versus 396 mM for dopamine at the human norepinephrine transporter or 0.60 mM vs 564 mM and 17 mM versus 7 mM for serotonin and MPP + , respectively, at the human serotonin transporter . The marked dierence in the K M value for inward and outward transport may be caused by several factors. Mabjeesh & Kanner (1989) studied GABA transport in inverted membrane vesicles from rat brain and noted that transport from the cytosolic side to the exterior had a 100 fold higher K M than transport from the exterior to the cytoplasm. Moreover, an increase in K M of substrate transport at low sodium concentrations is a well known phenomenon at other sodiumand chloride-dependent transporters (Graefe & BoÈ nisch, 1989) .
In conclusion, the present report provides corroborative evidence that outward transport of GABA by the rGAT-1 can readily be initiated by transporter substrates while uptake inhibitors do not exert this eect. Furthermore, data on quantitative aspects of inward and outward transport are provided and the complex interaction of DABA with the transporter is highlighted.
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